{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T23:24:38Z","timestamp":1786922678882,"version":"build-2736575974"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":68,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Shiyan City Science and Technology Bureau Research Guidance Project","award":["25Y158"],"award-info":[{"award-number":["25Y158"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Res"],"DOI":"10.1186\/s13550-026-01452-6","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T09:04:02Z","timestamp":1781082242000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Complementary roles of 68Ga-FAPI and 18\u00a0F-FDG PET\/CT in evaluating IgG4-related disease: a systematic review and pooled analysis"],"prefix":"10.1186","volume":"16","author":[{"given":"Xue","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingfan","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"issue":"15","key":"1452_CR1","doi-asserted-by":"publisher","first-page":"e680","DOI":"10.1097\/MD.0000000000000680","volume":"94","author":"D Inoue","year":"2015","unstructured":"Inoue D, Yoshida K, Yoneda N, et al. IgG4-related disease: dataset of 235 consecutive patients. Medicine. 2015;94(15):e680. https:\/\/doi.org\/10.1097\/MD.0000000000000680.","journal-title":"Medicine"},{"issue":"11","key":"1452_CR2","doi-asserted-by":"publisher","first-page":"e703","DOI":"10.1016\/S2665-9913(20)30286-5","volume":"2","author":"M Lanzillotta","year":"2020","unstructured":"Lanzillotta M, Mancuso G, Della-Torre E. IgG4-related disease. LANCET RHEUMATOL. 2020;2(11):e703\u201317. https:\/\/doi.org\/10.1016\/S2665-9913(20)30286-5.","journal-title":"LANCET RHEUMATOL"},{"issue":"1","key":"1452_CR3","first-page":"119","volume":"34","author":"Z Zhao","year":"2016","unstructured":"Zhao Z, Wang Y, Guan Z, et al. Utility of FDG-PET\/CT in the diagnosis of IgG4-related diseases. CLIN EXP RHEUMATOL. 2016;34(1):119\u201325. PMID: 26842851.","journal-title":"CLIN EXP RHEUMATOL"},{"issue":"1","key":"1452_CR4","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/acr.22058","volume":"66","author":"M Ebbo","year":"2014","unstructured":"Ebbo M, Grados A, Guedj E, et al. Usefulness of 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography\/computed tomography for staging and evaluation of treatment response in IgG4-related disease: a retrospective multicenter study. Arthrit Care Res. 2014;66(1):86\u201396. https:\/\/doi.org\/10.1002\/acr.22058.","journal-title":"Arthrit Care Res"},{"issue":"13","key":"1452_CR5","doi-asserted-by":"publisher","first-page":"4434","DOI":"10.1007\/s00259-022-05953-z","volume":"49","author":"Y Pang","year":"2022","unstructured":"Pang Y, Zhao L, Luo Y, et al. [68Ga]Ga-FAPI-04 PET\/CT in non-oncological diseases: a review and future perspectives. Eur J Nucl Med Mol I. 2022;49(13):4434\u201348. https:\/\/doi.org\/10.1007\/s00259-022-05953-z.","journal-title":"Eur J Nucl Med Mol I"},{"issue":"12","key":"1452_CR6","doi-asserted-by":"publisher","first-page":"4193","DOI":"10.1021\/acsptsci.4c00641","volume":"8","author":"F Kalantari","year":"2025","unstructured":"Kalantari F, H\u00f6rmann AA, Pokarowski M, et al. Fibroblast Activation Protein Inhibitor (FAPI)-Radioligand PET\/CT in the Assessment of Nononcological Diseases: A Narrative Review. Acs Pharmacol Transl. 2025;8(12):4193\u2013213. https:\/\/doi.org\/10.1021\/acsptsci.4c00641.","journal-title":"Acs Pharmacol Transl"},{"issue":"8","key":"1452_CR7","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1007\/s00259-021-05646-z","volume":"49","author":"K Hu","year":"2021","unstructured":"Hu K, Wang L, Wu H, et al. [18F]FAPI-42 PET imaging in cancer patients: optimal acquisition time, biodistribution, and comparison with [68Ga]Ga-FAPI-04. Eur J Nucl Med Mol I. 2021;49(8):2833\u201343. https:\/\/doi.org\/10.1007\/s00259-021-05646-z.","journal-title":"Eur J Nucl Med Mol I"},{"issue":"2","key":"1452_CR8","doi-asserted-by":"publisher","first-page":"266","DOI":"10.2967\/jnumed.120.244723","volume":"62","author":"Y Luo","year":"2020","unstructured":"Luo Y, Pan Q, Yang H, et al. Fibroblast Activation Protein-Targeted PET\/CT with 68Ga-FAPI for Imaging IgG4-Related Disease: Comparison to 18F-FDG PET\/CT. J Nucl Med. 2020;62(2):266\u201371. https:\/\/doi.org\/10.2967\/jnumed.120.244723.","journal-title":"J Nucl Med"},{"key":"1452_CR9","doi-asserted-by":"publisher","unstructured":"Lartey DA, Schilder LA, Zwezerijnen GJC, et al. FAPi PET\/CT Imaging to Identify Fibrosis in Immune-Mediated Inflammatory Diseases. Biomedicines. 2025;13(4). https:\/\/doi.org\/10.3390\/biomedicines13040775.","DOI":"10.3390\/biomedicines13040775"},{"issue":"5","key":"1452_CR10","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s11307-024-01928-8","volume":"26","author":"L Wan","year":"2024","unstructured":"Wan L, Sun C, Liang J, et al. Volume-Based Quantitative Measurement of [18F]AlF-NOTA-FAPI-04 PET\/CT Uptake Reflects the Disease Activity of IgG4-Related Disease. Mol Imaging Biol. 2024;26(5):753\u201360. https:\/\/doi.org\/10.1007\/s11307-024-01928-8.","journal-title":"Mol Imaging Biol"},{"issue":"4","key":"1452_CR11","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1055\/a-2127-7699","volume":"62","author":"\u0130 Kaplan","year":"2023","unstructured":"Kaplan \u0130, Kepenek F, G\u00fczel Y, et al. The Role of 68Ga FAPI-04 and 18F-FDG PET\/CT in Detecting Liver Metastases in Different Types of Cancer. Nuklearmed-Nucl Med. 2023;62(4):252\u20139. https:\/\/doi.org\/10.1055\/a-2127-7699.","journal-title":"Nuklearmed-Nucl Med"},{"issue":"2","key":"1452_CR12","doi-asserted-by":"publisher","first-page":"e220749","DOI":"10.1148\/radiol.220749","volume":"306","author":"Y Mori","year":"2023","unstructured":"Mori Y, Dendl K, Cardinale J, et al. FAPI PET: Fibroblast Activation Protein Inhibitor Use in Oncologic and Nononcologic Disease. Radiology. 2023;306(2):e220749. https:\/\/doi.org\/10.1148\/radiol.220749.","journal-title":"Radiology"},{"issue":"3","key":"1452_CR13","doi-asserted-by":"publisher","first-page":"e141","DOI":"10.1097\/RLU.0000000000003489","volume":"46","author":"P Sharma","year":"2021","unstructured":"Sharma P, Singh SS, Gayana S. Fibroblast Activation Protein Inhibitor PET\/CT: A Promising Molecular Imaging Tool. Clin Nucl Med. 2021;46(3):e141\u201350. https:\/\/doi.org\/10.1097\/RLU.0000000000003489.","journal-title":"Clin Nucl Med"},{"issue":"3","key":"1452_CR14","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1007\/s00259-025-07608-1","volume":"53","author":"AS Abdlkadir","year":"2025","unstructured":"Abdlkadir AS, Ardalan Z, Scott AM, et al. Diagnostic utility of FDG and FAPI PET imaging in crohn\u2019s disease: a systematic review and meta-analysis. Eur J Nucl Med Mol I. 2025;53(3):1434\u201344. https:\/\/doi.org\/10.1007\/s00259-025-07608-1.","journal-title":"Eur J Nucl Med Mol I"},{"key":"1452_CR15","doi-asserted-by":"publisher","DOI":"10.1093\/bjr\/tqaf020","author":"M Desaulniers","year":"2025","unstructured":"Desaulniers M, Rousseau \u00c9, Pabst KM. Clinical and Research Applications of FAPI Tracers: A Review. Brit J Radiol. 2025. https:\/\/doi.org\/10.1093\/bjr\/tqaf020.","journal-title":"Brit J Radiol"},{"issue":"12","key":"1452_CR16","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/s41584-020-0504-2","volume":"16","author":"CA Perugino","year":"2020","unstructured":"Perugino CA, Stone JH. IgG4-related disease: an update on pathophysiology and implications for clinical care. Nat Rev Rheumatol. 2020;16(12):702\u201314. https:\/\/doi.org\/10.1038\/s41584-020-0504-2.","journal-title":"Nat Rev Rheumatol"},{"issue":"9","key":"1452_CR17","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1097\/RLU.0000000000004761","volume":"48","author":"MA Elahmadawy","year":"2023","unstructured":"Elahmadawy MA, et al. 68Ga-FAPI PET\/CT in Inflammatory and Fibrotic Diseases: Beyond Oncology. Clin Nucl Med. 2023;48(9):765\u201373. https:\/\/doi.org\/10.1097\/RLU.0000000000004761.","journal-title":"Clin Nucl Med"},{"key":"1452_CR18","doi-asserted-by":"publisher","first-page":"1354093","DOI":"10.3389\/fimmu.2024.1354093","volume":"15","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Wang J, Li M, et al. The different manifestations of 18F-FDG PET\/CT and 68Ga-FAPI-04 PET\/CT in evaluation of the steroid therapy response for IgG4-related disease: A case report. Front Immunol. 2024;15:1354093. https:\/\/doi.org\/10.3389\/fimmu.2024.1354093.","journal-title":"Front Immunol"},{"issue":"1","key":"1452_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4103\/0256-4947.75771","volume":"31","author":"A Almuhaideb","year":"2011","unstructured":"Almuhaideb A, Papathanasiou N, Bomanji J. 18F-FDG PET\/CT imaging in oncology. Ann Saudi Med. 2011;31(1):3\u201313. https:\/\/doi.org\/10.4103\/0256-4947.75771.","journal-title":"Ann Saudi Med"},{"issue":"3","key":"1452_CR20","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1007\/s00259-025-07576-6","volume":"53","author":"S Sadeghpour","year":"2025","unstructured":"Sadeghpour S, Aghaee A, Ahmadzadehfar H, et al. Revealing the hidden: A systematic review and meta-analysis of FAPI-based tracers imaging for brain metastatic lesions. Eur J Nucl Med Mol I. 2025;53(3):1419\u201333. https:\/\/doi.org\/10.1007\/s00259-025-07576-6.","journal-title":"Eur J Nucl Med Mol I"},{"key":"1452_CR21","doi-asserted-by":"publisher","unstructured":"Manuppella F, Pisano G, Taralli S, et al. Diagnostic Performances of PET\/CT Using Fibroblast Activation Protein Inhibitors in Patients with Primary and Metastatic Liver Tumors: A Comprehensive Literature Review. Int J Mol Sci. 2024;25(13). https:\/\/doi.org\/10.3390\/ijms25137197.","DOI":"10.3390\/ijms25137197"},{"issue":"4","key":"1452_CR22","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s11307-022-01715-3","volume":"24","author":"E Novruzov","year":"2022","unstructured":"Novruzov E, Dendl K, Ndlovu H, et al. Head-to-head Intra-individual Comparison of [68Ga]-FAPI and [18F]-FDG PET\/CT in Patients with Bladder Cancer. Mol Imaging Biol. 2022;24(4):651\u20138. https:\/\/doi.org\/10.1007\/s11307-022-01715-3.","journal-title":"Mol Imaging Biol"},{"issue":"12","key":"1452_CR23","doi-asserted-by":"publisher","first-page":"7804","DOI":"10.1007\/s00330-024-10843-z","volume":"34","author":"R Tang","year":"2024","unstructured":"Tang R, Liu M, Shu Q, et al. Performance of fibroblast activating protein inhibitor PET imaging for pancreatic neoplasms assessment: a systematic review and meta-analysis. Eur Radiol. 2024;34(12):7804\u201312. https:\/\/doi.org\/10.1007\/s00330-024-10843-z.","journal-title":"Eur Radiol"},{"issue":"3","key":"1452_CR24","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1007\/s00259-022-06022-1","volume":"50","author":"J Zhang","year":"2022","unstructured":"Zhang J, He Q, Jiang S, et al. [18F]FAPI PET\/CT in the evaluation of focal liver lesions with [18F]FDG non-avidity. Eur J Nucl Med Mol I. 2022;50(3):937\u201350. https:\/\/doi.org\/10.1007\/s00259-022-06022-1.","journal-title":"Eur J Nucl Med Mol I"},{"issue":"3","key":"1452_CR25","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1055\/s-0044-1787718","volume":"23","author":"G Gunasekaran","year":"2024","unstructured":"Gunasekaran G, Amalachandran J. 68Ga-FAPI PET\/CT versus 18F-FDG PET\/CT: Differentiating Metastatic Disease and Reactive Lymph Nodes in a Case of Carcinoma of Breast\/Acquired Immunodeficiency Syndrome. World J Nucl Med. 2024;23(3):217\u20139. https:\/\/doi.org\/10.1055\/s-0044-1787718.","journal-title":"World J Nucl Med"},{"issue":"5","key":"1452_CR26","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.4049\/jimmunol.174.5.2517","volume":"174","author":"J Westermann","year":"2005","unstructured":"Westermann J, Bode U, Sahle A, et al. Naive, effector, and memory T lymphocytes efficiently scan dendritic cells in vivo: contact frequency in T cell zones of secondary lymphoid organs does not depend on LFA-1 expression and facilitates survival of effector T cells. J Immunol. 2005;174(5):2517\u201324. https:\/\/doi.org\/10.4049\/jimmunol.174.5.2517.","journal-title":"J Immunol"},{"issue":"3","key":"1452_CR27","doi-asserted-by":"publisher","first-page":"386","DOI":"10.2967\/jnumed.118.215913","volume":"60","author":"FL Giesel","year":"2019","unstructured":"Giesel FL, Kratochwil C, Lindner T, et al. 68Ga-FAPI PET\/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers. J Nucl Med. 2019;60(3):386\u201392. https:\/\/doi.org\/10.2967\/jnumed.118.215913.","journal-title":"J Nucl Med"},{"issue":"12","key":"1452_CR28","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.2967\/jnumed.123.265751","volume":"64","author":"TT Demmert","year":"2023","unstructured":"Demmert TT, Pomykala KL, Lanzafame H, et al. Oncologic Staging with 68Ga-FAPI PET\/CT Demonstrates a Lower Rate of Nonspecific Lymph Node Findings Than 18F-FDG PET\/CT. J Nucl Med. 2023;64(12):1906\u20139. https:\/\/doi.org\/10.2967\/jnumed.123.265751.","journal-title":"J Nucl Med"},{"issue":"4","key":"1452_CR29","doi-asserted-by":"publisher","first-page":"350","DOI":"10.4103\/0972-3919.164018","volume":"30","author":"K Oksuzoglu","year":"2015","unstructured":"Oksuzoglu K, Ozen G, Inanir S, et al. Flip-flop phenomenon in systemic sclerosis on fluorodeoxyglucose positron emission tomography\/computed tomography. Indian J Nucl Med. 2015;30(4):350\u20131. https:\/\/doi.org\/10.4103\/0972-3919.164018.","journal-title":"Indian J Nucl Med"},{"issue":"9","key":"1452_CR30","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.2967\/jnumed.123.265530","volume":"64","author":"X Chen","year":"2023","unstructured":"Chen X, Wang S, Lai Y, et al. Fibroblast Activation Protein and Glycolysis in Lymphoma Diagnosis: Comparison of 68Ga-FAPI PET\/CT and 18F-FDG PET\/CT. J Nucl Med. 2023;64(9):1399\u2013405. https:\/\/doi.org\/10.2967\/jnumed.123.265530.","journal-title":"J Nucl Med"},{"issue":"1","key":"1452_CR31","doi-asserted-by":"publisher","first-page":"101","DOI":"10.18999\/nagjms.82.1.101","volume":"82","author":"Y Ozawa","year":"2020","unstructured":"Ozawa Y, Yamamoto, Hiroshi, Yasuo M, et al. A comparison of the features of fluorine-18 fluorodeoxyglucose-positron emission tomography (FDG-PET) between IgG4-related disease with bilateral hilar lymphadenopathy and sarcoidosis. Nagoya J Med Sci. 2020;82(1):101\u201311. https:\/\/doi.org\/10.18999\/nagjms.82.1.101.","journal-title":"Nagoya J Med Sci"},{"key":"1452_CR32","doi-asserted-by":"publisher","unstructured":"Taniguchi Y, Ode K, Hirose K et al. AB0929\u2005The Serum Levels of Cholinesterase and Total Cholesterol PREDICT the Existence or Latency of Multiple Organs\u2019 Involvements in Japanese Patients with Igg4-Related Disease ANN RHEUM DIS. 2014; 73 (Suppl 2): 1107.3\u20131107. https:\/\/doi.org\/10.1136\/annrheumdis-2014-eular.4250","DOI":"10.1136\/annrheumdis-2014-eular.4250"},{"key":"1452_CR33","doi-asserted-by":"publisher","unstructured":"Taniguchi Y, Ogata K, Shimamura Y, et al. Splenic lesion of IgG4-related disease in FDG-PET\/CT Case Rep. Intern Med. 2014;1(2). https:\/\/doi.org\/10.5430\/crim.v1n2p150.","DOI":"10.5430\/crim.v1n2p150"},{"issue":"6","key":"1452_CR34","doi-asserted-by":"publisher","first-page":"801","DOI":"10.2967\/jnumed.119.227967","volume":"60","author":"C Kratochwil","year":"2019","unstructured":"Kratochwil C, Flechsig P, Lindner T, et al. 68Ga-FAPI PET\/CT: Tracer Uptake in 28 Different Kinds of Cancer. J Nucl Med. 2019;60(6):801\u20135. https:\/\/doi.org\/10.2967\/jnumed.119.227967.","journal-title":"J Nucl Med"},{"issue":"4","key":"1452_CR35","doi-asserted-by":"publisher","first-page":"634","DOI":"10.2967\/jnumed.124.268943","volume":"66","author":"S Liu","year":"2025","unstructured":"Liu S, Pan Q, Zhang H, et al. Differences in Fibroinflammatory Activity Shown on 68Ga-FAPI-04 and 18F-FDG PET\/CT in the Two Subtypes of IgG4-Related Disease. J Nucl Med. 2025;66(4):634\u201340. https:\/\/doi.org\/10.2967\/jnumed.124.268943.","journal-title":"J Nucl Med"},{"issue":"11","key":"1452_CR36","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1136\/annrheumdis-2020-217408","volume":"79","author":"C Schmidkonz","year":"2020","unstructured":"Schmidkonz C, Rauber, Simon, Atzinger A, et al. Disentangling inflammatory from fibrotic disease activity by fibroblast activation protein imaging. Ann Rheum Dis. 2020;79(11):1485\u201391. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217408.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"1452_CR37","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s12149-024-01932-w","volume":"38","author":"Y Tang","year":"2024","unstructured":"Tang Y, Li Y, Zhang X, et al. Diagnostic performance of F-18 FDG PET\/CT in differentiating autoimmune pancreatitis from pancreatic cancer: a systemic review and meta-analysis. Ann Nucl Med. 2024;38(6):455\u201365. https:\/\/doi.org\/10.1007\/s12149-024-01932-w.","journal-title":"Ann Nucl Med"},{"issue":"4","key":"1452_CR38","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1097\/RLU.0000000000002919","volume":"45","author":"Q Pan","year":"2020","unstructured":"Pan Q, Luo Y, Zhang W. Recurrent Immunoglobulin G4-Related Disease Shown on 18F-FDG and 68Ga-FAPI PET\/CT. Clin Nucl Med. 2020;45(4):312\u20133. https:\/\/doi.org\/10.1097\/RLU.0000000000002919.","journal-title":"Clin Nucl Med"},{"key":"1452_CR39","doi-asserted-by":"publisher","unstructured":"Ji H, Song, Xiangming, Lv X et al. [68Ga]FAPI PET for Imaging and Treatment Monitoring in a Preclinical Model of Pulmonary Fibrosis: Comparison to [18F]FDG PET and CT. Pharmaceuticals (Basel). 2024; 17 (6): https:\/\/doi.org\/10.3390\/ph17060726","DOI":"10.3390\/ph17060726"}],"container-title":["EJNMMI Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13550-026-01452-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-026-01452-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-026-01452-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T22:31:50Z","timestamp":1786919510000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13550-026-01452-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1452"],"URL":"https:\/\/doi.org\/10.1186\/s13550-026-01452-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8932863\/v1","asserted-by":"object"}]},"ISSN":["2191-219X"],"issn-type":[{"value":"2191-219X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"assertion":[{"value":"26 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"As this study is a systematic review and meta-analysis of publicly available data, it did not involve human or animal subjects. Therefore, ethical approval and informed consent were not required.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This study did not involve individual patient data or images.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"128"}}